Abstract
Tracer methodology using radioisotopes in human nutrition and metabolism research has been very productive but its use has been the object of unjustified limitations because of modeling decisions without adequate consideration of new data. These limitations have encumbered research studies in the metabolism of micro-and macronutrients particularly where nutritional deficiencies are prevalent. Even though stable isotope methodologies in human research are very useful in specific applications they are expensive and are often fraught with serious pitfalls, when compared to studies for the same purposes using radioisotopes. We have been developing safe radioisotopic methods to study the absorption and metabolism of micronutrients, especially iron and zinc, that can be applied to populations in the developing world. These and other applications of radioisotopes should allow scientists to conduct research diminishing the dependence on stable isotopes and on facilities and laboratories existing only in selected sites in the industrial world, and thus should enhance productive local and collaborative research. All radioisotopic research must be subjected to strict safety criteria, based on scientific evidence of risk, but should not be hampered by exaggerated fears of unfounded risk. Examples on the use of radio and stable isotopes to study iron and zinc absorptions are given including the radiation exposure and risk calculations.
Key words: Radioisotopes, human, use, nutrition, research Background Early history of ionizing radiation and research using radio and stable isotopes By the end of the nineteenth century very exciting research in chemistry and physics extended a conceptual revolution initiated early by Dalton, whose ideas of the atomic nature of matter and classification of elements based on atomic weights were continued by Mendeleev (1860s) who proposed the classification of the elements by their periodic properties. Then came the discovery of x-rays by Roentgen in 1895, the discovery by Becquerel of ∝ particles emitted by uranium (radioactivity) in 1896, the isolation of Polonium and Radium by the Curies in 1898, the discoveries of β and γ radiation, and Einstein's theories, all by 1905. Many discoveries followed and the biological effects of ionizing radiation (IR) became clearer, including the discovery of its mutagenic capacity by Mueller in 1927 [1] .
The use of radioisotopes in biological research had already been initiated in the 1920s by G. Hevesy who, with rather unique insights and ingenious methods, studied the distribution of naturally occurring radioisotopes of lead, bismuth, and thorium in plants and initiated studies in animals on the distribution and metabolism of 32 P. A key step in the use of isotopes in metabolism came from the studies by Schoenheimer who used the stable deuterium ( 2 H) extensively to develop his concept of "the dynamic state of body constituents" [2] . For the purposes of this paper an important step was achieved by Joliot-Curie and Joliot who produced the first artificial radioisotopes in 1934. Their use in biological research, including studies in humans, was significantly increased the world over by the discovery of atomic fission in 1938 and later, particularly after 1945, with the greater availability of radio- 
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isotopes. Knowledge on metabolic processes and new analytical, diagnostic, and therapeutic methodologies using radioisotopes were greatly expanded. However, early in their use less stringent monitoring of doses was in place compared to that demanded today. This stringent monitoring is prudent because unintentional harm was caused in some instances as in the Vanderbilt iron absorption study in pregnancy by Hahn et al. in 1951 [3] , which gave rise to a notorious suit resolved in 1994 by compensating affected families [4] .
Essential parts of this paper are some background considerations on the current regulation of the use of ionizing radiation (IR). As early as 1900, evidence was collected which showed that IR could produce damage to biological systems. This promoted the creation of scientific groups such as the American Roentgen Ray Society (ARRS). Later, these groups began taking the role of regulatory agencies. Radiation protection was begun in 1915 by the British Roentgen Society, and by 1928 the International Commission on Radiation Protection (ICRP) was established [1] .
The biological effects of high IR doses gave origin to regulations on their use aimed at reducing to a minimum the health risks attributed to IR exposure. A linear model based on the stochastic effects of large IR doses extrapolated health risks to exposure doses thousands of times smaller than those where evidence of biological and health damage existed so that no dose of IR was considered safe. Therefore, the minimal doses currently used in human metabolic research are considered to carry health risks, even though these have never been demonstrated. It is our opinion that an unjustified fear to the prudent use of radioisotopes in human research has permeated society as a consequence of the linear extrapolation models adopted by regulatory agencies.
Up to the 1950s the main concerns were on the detection of genetic effects caused by IR but now other aspects are of greater concern, especially the development of cancer, and the mechanisms involved in cancer initiation and promotion and in the biological reactions secondary to the interactions of IR with biological systems.
In 1945 the Hiroshima and Nagasaki atomic bomb explosions took place. The U. S. Atomic Energy Commission was created in 1946; and in1957 the International Atomic Energy Agency (IAEA) was established by the United Nations "to seek to accelerate and enlarge the contributions of atomic energy to peace, health, and prosperity throughout the world and to guide and promote the peaceful uses of atomic energy." These and other agencies were responsible for the promotion and prudent use of IR including human radiotracer and diagnostic techniques which have resulted in significant advances in many useful applications of IR, including fundamental tracer-based metabolic and nutritional knowledge. [1, 5 (p. 9-31) , 6]
Useful terms and units
Linear energy transfer
The physical principle behind the effects of IR is the linear energy transfer (LET) of IR-energy to matter, which depends on: a) (The charge of the incident particles) 2 , b) The electron density of the absorber, and c) (The velocity of the incident particle) -1 .
As the electrochemical energy of IR is absorbed, ions are produced mainly in the predominant cellular medium, which is water. These activated chemical ions are "free radicals" capable of changing the structure of cellular molecules, cell function, and life cycle (i.e., arrest or acceleration of cell division and apoptosis), and inducing DNA damage with all its consequences. These can be negative, as in the case of double strand DNA breaks, or even positive by activation of protective reactions against free radicals and reactive oxygen species (ROS), and DNA repair mechanisms. Direct hits to nucleus and DNA and their consequent damage from absorbing all the IR energy are rare in low doses of low LET radiation. X-rays, gamma rays, and β radiation are examples of low LET radiation. Alpha particles, neutrons, and some other uncharged radiation are examples of types of high LET radiation, because they generate high numbers of secondary charged particles in water, becoming very damaging ( fig. 1 ). High LET radioisotopes are not used in metabolic studies, although neutron activation analysis can be used with caution.
Radiation units
The radiation units commonly used for the absorbed dose (or simply the dose) are the traditional rad and the newer SI unit, the Gray (Gy). One Gy = 100 rads. One rad is biologically equivalent to one roentgen (R). The units of risk derived from the absorbed dose, resulting from the dose and the quality factor (Q), itself derived from the LET for different kinds of IR, are the traditional rem (roentgen-equivalent-man) and the newer SI unit, the Sievert (Sv). One Sv = 100 rems.
Relative hazard (H)
The relative hazard (H) of IR delivered by different radioisotopes depends on the amount of radioactive material, A, the toxicity factor of the radioisotope, T, and the use factor, U (H = ATU). Relative toxicity factors (T) have been established by diverse studies and the great majority of radioisotopes employed in human tracer research have a T of 1, compared to 100 for α radiation. 3 H has a T of 0.1, and 22 Na, 47 Ca, 125 I, 140 Ba have a T of 10. The use factor (U) is the fraction of the IR that is affecting the "target" organ or tissue.
Equivalent dose
The equivalent dose (H T ) a tissue or organ receives from IR is the product of the average absorbed dose in that tissue or organ and a radiation weighting factor (W T ) for each radiation. This quantity is intended to correlate, independently of each tissue, with the overall detriment to the whole individual. The US National Commission on Radiation Protection (NCRP) specifies a W T of 1 for X and γ rays, electrons, positrons and muons.
The fact that different tissues respond differently to IR requires that such differences in stochastic responses be weighed in order to calculate total body radiation. This is achieved by considering specific tissue weighting factors which when added sum up to 1. These factors are related to tissue turnover rates and range from 0.2 for gonads to 0.01 for bone surface. The risk derived from considering all stochastic effects is represented by the effective dose (E) and is expressed in rems or Sv: E = ∑ H T W T . When whole body radiation is uniform E T = H T because the sum of W T is 1. However, when a radionuclide enters the body it becomes distributed in various organs and tissues in different concentrations and remains there for different times. The total dose received by an organ or tissue over time is the integrated Committed Equivalent Dose of H T for that tissue or organ over time. By convention the time estimates are 50 or 70 years, for IR exposed adults and for IR exposed children, respectively. Following this reasoning, the committed effective dose equivalent (CEDE) as recommended by the International Com-mission on Radiation Protection 30 [7] is the weighted sum of all the committed equivalent doses for all tissues exposed to IR.
Low doses of linear energy transfer ionizing radiation
The evidence or lack of it that low doses of low linear energy transfer (LET) ionizing radiation (IR), similar to those used in tracer radioisotopic studies in nutritional and metabolic research may be damaging, indifferent, or even beneficial is presented below. A consequence of these findings should be a modification of the current linear model for estimating risk for others that include a threshold.
DNA damage, other undesirable cellular effects, and their health and developmental consequences due to high doses of ionizing radiation as well as factors that modify them are well documented. Table 1 summarizes the biochemical effects, the cellular defense or control mechanisms, and the cell to cell communications (clastogenic responses) which amplify these control mechanisms. Table 2 summarizes the end results of these changes due to high doses in terms of cell function and health, as well as the factors that modify the effects of a given dose.
In contrast to the demonstrated effects of high ionizing radiation doses, the effects of very low radiation doses are less well known. Human, animal, and in vitro tissue studies seem to indicate that low LET radiation at low doses, especially those delivered at low dose rates (days rather than minutes or hours), do not cause Low LET is produced by electromagnetic radiations and by low-energy electrons. X-rays and gamma rays produce a cascade of ions by exciting electrons which damage DNA and membrane structures.
Low energy radiation and electrons lose most of their energy with the first collision with other sub-atomic particles.
Radioisotopes used in research with humans have low LET.
High LET is produced by alpha particles, highenergy X-and gamma rays and high-energy electrons. These are very damaging to cells and their structures and are not used in human research.
short-or long-term undesirable effects (table 3) and often perturb, in a favorable way, physiological signaling pathways leading to accelerated DNA repair and increased defenses against free-radical damage [8, 9] . This phenomenon is known as hormesis (table 4) . Our interpretation of current scientific data agree with the conclusions arrived by the Health Physics Society [10] which indicate that health risks due to IR cannot be estimated quantitatively "below an individual dose of 5 rem (0.05 Sv) in one year or a lifetime dose of 10 rem (0.1 Sv) in addition to background radiation," which is estimated to be 200 to 300 mRem/year in the United States and about 250 mRem/year in the United Kingdom [6, 11] .
Cancer incidence
No increment in cancer incidence during the remaining years of life among persons exposed to low IR levels has been detected, even when IR sources are high LET. This is in part because "natural" cancer deaths are high (~20% of all deaths in the USA). From linear extrapolations of stochastic incidences of extra cancer deaths from high radiation doses, the Biological Effects of Ionizing Radiation fifth committee report (BEIR-V) [5, p. 9-31] arrives at a figure that for every whole body dose of 100 mGy (10 rads) to all the population the number of cancer cases per 100,000 individuals would increase from about 20,000 to 20,800 over the life-times of all individuals (note that the error in the estimate of "naturally" occurring cancer deaths is close to 4,000 2 ). According to the atomic bomb survivors study, leukemia develops relatively early and solid tumors appear later and cause more deaths. The leukemia incidence, however, appears lower than the "natural" incidence when the IR doses to bone marrow were lower than about 20 rems (0.2 Sv) suggesting a hormetic effect [13, 14] (fig. 3 ). Other data suggesting a hormetic effect have been obtained in the case of lung cancer incidence and radon exposure in miners as well as in workers in nuclear reactors. Lung cancer incidence among the miners receiving less than 6 Gy/year was not elevated and actually declined as air radon concentration increased within these low radiation exposures. This contrasts with the predicted increases in incidence by the linear regression model [15, 16] . Mortality due to all causes, leukemia, lymphatic, and all blood cancers was lower in nuclear reactor workers than in nonexposed workers* ( fig. 4 ). TABLE 4 . Hormesis: "Stimulatory or beneficial effect observed when a biological system is exposed to a low dose of an agent known to be toxic or damaging at a significantly larger dose" Examples » In lymphocyte cultures, DNA repair and free radical protecting enzymes are enhanced by exposure to low doses of ionizing radiation (IR). The result is that previous exposure to low IR doses protects from the effects of subsequent exposure to large IR doses not only in the cells receiving a hit (where LET occurs) but also in surrounding cells and in extra-cellular media by clastogenic mechanisms. » Intestinal cell renewal increases readily when exposed to continuous low IR levels. » Spleen plaque-forming cells in mice are stimulated by exposure to 25 to 75 mGy. » Irradiated mice and guinea pigs have a slightly greater life span than controls and develop less tumors at standardized ages. » Lower lung cancer incidences than expected have been noted in plutonium-plant workers chronically exposed to low IR as well as in individuals exposed to low radon levels. » High natural background radiation in different parts of the world (Brazil, China, France, India, Iran, Italy, Madagascar, and Nigeria) show lower or the same cancer mortality rates as control populations, even though higher prevalence of apparently innocuous chromosomal aberrations have been found in some areas. » Strains of non-obese, insulin-dependent diabetic mice subjected to low IR doses are protected from developing the clinical syndrome and exhibit less apoptosis of insulin producing cells as well as stimulated activities of several enzymes in antioxidant defense systems and DNA repair. 
Other effects
The fetus is more susceptible to IR than adults [17] and the moment of exposure to the same high dose of ionizing radiation has different consequences. For example, experimentally, the embryo and the fetus express radiation damage in different forms: death occurs when irradiation exposure takes place in the pre-implantation period; malformations (teratogenesis) occurs during organogenesis; and no immediate damage occurs during the final stages of pregnancy [17] [18] [19] but may manifest higher cancer incidence (especially leukemia) early in life [20] . In the human these gestational developmental stages correspond to 9 days, 10 days to 25 weeks, and 26 weeks or later. Fetal exposure to doses (≥ 1Gy) when brain organogenesis is at its peak (gestational weeks 8 to 25) in the human, produces significant mental retardation but has no effect in these functions from week 26 onwards [18] ( fig. 5 ).
Mutations due to damages to genetic material caused by IR were recognized early in the twentieth century, and experimentally the genetic effects of radiation have been well documented in a large variety of living organisms. However, these damages in different species can not be extrapolated with confidence to the human. For example, data from children exposed to IR from atomic explosions in Japan strongly suggest that humans are less susceptible to radiation damage than mice.
The genetic effects of low doses of low LET IR in the human are still obscure mainly because of several limitations in assessing them. They are not expressed in the person exposed (cancer is possibly an exception). They are expressed in their immediate or remote offspring. When population studies are performed the doses received, the sex, age, and rates of exposure are different, not uniform nor randomly distributed. In addition, all reproductive cells have spontaneouslyoccurring genetic alterations and small increments in genetic damage due to low IR doses in the human are very difficult to estimate. The BEIR V report arrives at an estimate that the doubling dose for genetic defects in humans is greater than 1Sv (100 rems) and that an equilibrium on clinically mild dominant genetic disorders is reached at 75 cases per million when a population is exposed to 1 rem per generation (the current spontaneous incidence is 7,500/million liveborn offspring). All other genetic defects are much lower, including clinically severe, X-linked, recessive, chromosomal translocations and trisomies, congenital abnormalities, and other disorders of complex etiology, such as heart disease, cancer, and "selected others" [5, p. 65-134 ]. 
Implications on extrapolation models on the negative effects of low doses of low LET ionizing radiation
Mounting evidence from studies outlined in table 3  and in figures 3 and 4, strongly suggests that there is a threshold for detectable negative effects consequent to low IR doses of low LET and that there can actually be beneficial effects through the phenomenon of hormesis which consists in "a stimulatory or beneficial effect observed when a biological system is exposed to a low dose of an agent known to be toxic or damaging at a significantly larger dose." Examples of hormesis triggered by low IR abound [8, [22] [23] [24] [25] [26] [27] [28] [29] and are summarized in table 4. Based on the above evidence and on the mechanisms involved in response to low IR doses, the development of guidelines for estimating the hazard associated with them based on linear regression models must be reviewed and changed for either a lower risk or a threshold/hormesis model ( fig. 6 ). If these risk models are adopted by regulatory agencies, new guidelines on the permissible use of radiation doses will allow further prudent use of radioisotopes in tracer studies in humans.
Nutritional and metabolic research using radioisotopes has contributed significantly to our knowledge, as exemplified by the number of studies and programs supported, for example by the International Atomic Energy Agency (IAEA) [30] [31] [32] and the U.S. Government [33, 34] . Importantly, the majority of studies, even using long-physical-life isotopes have had committed effective dose equivalents (CEDEs) within the low area of undetectable effects (table 5) In summary, all evidence indicates that when radioisotopes are properly applied, resulting in low CEDES, the health risk is at most, undetectable because it is very low, nil, or may be even protective. In our opinion, the linear no threshold model should be abandoned for a model that accurately depicts the true risks, or lack of them when low dose, low rate, low LET radiation is used.
Comparison of benefits, limitations, availability, and relative costs of tracer studies using radioisotopes and stable isotopes
There is no question that studies in humans using stable isotopes have contributed significantly to our knowledge, and should be promoted. A few exemplary contributions are measuring long-term total energy expenditure with doubly-labeled water, in vivo elucidation of metabolic pathways using 13 C and 2 H labeled molecules and pool sizes and fluxes by using 70 Zn and 67 Zn [35] [36] [37] .
Unfortunately there are serious obstacles to the ample use of stable isotope studies where most nutritional deficiencies exist. These include the often limited isotope availability, their cost, the necessity of expensive equipment affordable only by a few special research settings, the serious technical difficulties in achieving and maintaining standardized and reliable results, and the need of highly trained professionals for maintenance Coordinated research program on isotopic-aided studies of the bioavailability of iron and zinc from human diets and fortificants (12 countries, 10 of them developing) (1990) (1991) (1992) (1993) . Methodology development and its application in nutrition.
The majority took place up to 1974,but micro-nutrient bioavailability studies and others (iron, zinc, body composition)are ongoing at present (1999) (2000) (2001) in selected populations.
Human metabolic research involving the following radioisotopes: 131 I, 14 C, 3 H, 24 Na, 54 Mn, 28 Mg, 36 and operation of the sophisticated mass spectrometers required for many specialized metabolic studies.
To these factors must be added the fact that in some micronutrient tracer studies, the need to administer isotope doses large enough to achieve measurable tracer to tracee ratios (relative enrichments) making them not truly tracer studies. For example, the addition of 4 mg of 57 Fe to a meal, necessary for reliably detecting 57 Fe enrichment of hemoglobin, alters the ratio of iron to phytates and to other minerals in that meal. This is not the case for either 55 Fe or 59 Fe, where only micrograms of high specific activity tracers are used [38] [39] [40] [41] . Table 6 compares the costs of doing metabolic studies in iron and zinc absorption and metabolism. The results of these comparisons are evident. Many other studies using stable isotopes are more expensive even by several orders of magnitude. However, one must profit from advantages in the use of stable and radioisotopic methodologies. For example, we are developing a combination of double stable and single radioisotope methods to validate and standardize measurements of zinc absorption applicable to population studies* [42].
Radioisotopic-aided nutritional and metabolic studies with emphasis on the committed effective dose equivalent (CEDE) administered to humans
We have performed a series of studies on iron and zinc absorption and metabolism using radioisotopes and or combinations of radio and stable isotopes. Table 7 presents the radiation doses administered and their CEDEs, estimated by following the ICRP 30 [7] guidelines.
In terms of excess radiation over the mean yearly natural radiation in the United States and the United Kingdom (200 to 300 mRem/year, or about 2.5 mSv/ year), the CEDE amounts to 5.4% for 59 Fe, to 0.96% for 55 Fe and to 15.8% for 65 Zn above the natural yearly background radiation. Expressed in other terms, the excess CEDE amounts to 19.7 days for 59 Fe, to 3.5 days for 55 Fe and to 57.8 days for 65 Zn, above the 365 days of natural background radiation in a year. These data indicate that these CEDEs are near the extreme left of the region where no effects are detected and in the region where hormesis is prone to occur.
Conclusions and recommendations
The dose-risk model being used to establish regulatory IR dose limits assumes a linear relationship with no threshold above zero dose, suggesting that any amount of radiation is damaging. Evidence against this model abounds, indicating a lower risk or a threshold/ hormesis model, even resulting in beneficial effects of low LET radiation dose. The bodies recommending appropriate standards for protecting radiation workers and the general public have been aware of the non linear relationship of dose and risk for low total IR dose and dose rates for low LET radiation. In spite of this, the conservative approach taken by these agencies has resulted, over the years, in an unquestioned belief that "there is no safe IR dose," leading to an excessive societal concern regarding the use of minimal amounts of radioactive isotopic material such as those being employed in human tracer research.
The Health Physics Society [10] , referring to dose and risk for low dose exposures, "recommends against quantitative estimation of health risks below an individual dose of 5 rem in one year or a lifetime dose of 10 rem in addition to background radiation. Below these dose levels risk estimates should not be used." More research needs to be done in order to reduce the uncertainties in risk assessment models of low LET IR [8] . (This is ongoing from genomic expressions to long-lasting epidemiological research). Important research in nutrition and metabolism has been hampered because of an overestimated fear of radioisotopic tracer studies. Unfortunately, most stable-isotopicbased research is extremely expensive and often less reliable than radiotracer studies, limiting their application. Combined use of stable and radio isotopes should be explored further.
The IAEA and affiliated centers should make better known their health physics expertise and their capability to advise, support, and monitor researchers on the safe use of radioisotopes in human and animal nutritional and metabolic research. They should take advantage of all communication means available now to produce a template to be filled by all researchers using radioactive tracers. Additional advice and support, based on this template, should be provided by the Agency and its affiliated centers.
Considering the accumulated evidence that low IR doses of low LET have no harmful effects and may be even beneficial, the regulatory agencies must conduct a public information campaign following and expanding the Health Physics Society statements. This campaign should be addressed to eradicate the unfounded fear of using prudent doses in tracer radioisotope-based research. Therefore, in all cases the CEDE is less than 40% of the yearly permissible dose.
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